- Home
- ZGM vs BOLD Comparison
ZGM vs BOLD Comparison
Compare ZGM & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZGM | BOLD |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | Macau | United States |
| Employees | 9 | N/A |
| Industry | Professional Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0M | 25.7M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | ZGM | BOLD |
|---|---|---|
| Price | $1.93 | $1.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 4.0K | ★ 139.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.53 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $20.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.73 | $0.96 |
| 52 Week High | $4.44 | $1.83 |
Technical Indicators
Market Signals| Indicator | ZGM | BOLD |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 44.71 |
| Support Level | $1.73 | $1.10 |
| Resistance Level | $2.33 | $1.19 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 32.09 | 40.00 |
Price Performance
Historical ComparisonAbout ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is a professional services provider in Macau, offering industrial park consulting services, business investment consulting services through LIC, and the sale of fintech products and services through LFT. Its industrial park consulting services focus on the pre-development stage, assisting with applications and negotiations for industrial park projects with PRC government authorities, with plans to expand into post-development services through LMS. The business investment consulting services mainly involve assisting clients in acquiring equity stakes in technology firms, private equity management firms, and industrial park project firms, supported by third-party professionals. The Group operates in Macau and the PRC, generating the majority of its revenue from the PRC.
About BOLD Boundless Bio Inc.
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.